COMMUNIQUÉS West-GlobeNewswire

TOMI Environmental Solutions, Inc. Secures EPA Registration in Taiwan

26/03/2018 - 15:00

BEVERLY HILLS, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ) a global company that specializes in plasma science based disinfection/decontamination technology using [...]

CohBar, Inc. Announces Financing of up to US$5,000,000 in Unsecured Promissory Notes

26/03/2018 - 15:00

MENLO PARK, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR ) and (TSXV:COB.U) (“CohBar” or the “Company”), a preclinical stage biotechnology company developing mitochondria based therapeutics to [...]

Bravo Becomes First National Wellness Vendor to Endorse Campaign for Universal Access to Health Promotion

26/03/2018 - 15:00

CLEVELAND, Ohio, March 26, 2018 (GLOBE NEWSWIRE) -- Today, Bravo, the leading national provider of employee well-being solutions known for success in measurable health risk reductions, announces its public support for [...]

Cesca Therapeutics Announces Registered Direct Offering

26/03/2018 - 15:00

RANCHO CORDOVA, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, announced that it has [...]

MyVii Foundation Releases new STD awareness campaign “Spread the AFFECTION not the INFECTION”

26/03/2018 - 15:00

TORONTO, March 26, 2018 (GLOBE NEWSWIRE) -- MyVii Foundation (Non-Profit) On February 13 th of this year, Maren Melnick discovered that several of her friends were recently diagnosed with an STD. That same day she [...]

Share buy-back week 12/2018

26/03/2018 - 14:43

Announcement 26 March 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]

Micron Solutions, Inc. Reports 2017 Fourth Quarter and Year End Results

26/03/2018 - 14:31

FITCHBURG, Mass., March 26, 2018 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American:MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]

Precision Therapeutics to Hold Business Update Conference Call on April 2, 2018

26/03/2018 - 14:30

MINNEAPOLIS, March 26, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, a company focused on applying artificial intelligence to personalized [...]

Onconova Presents Promising Data from Phase 2 Expansion Study of Oral Rigosertib and Azacitidine Combination in Patients with Myelodysplastic Syndromes at 6th International Bone Marrow Failure Disease Symposium

26/03/2018 - 14:30

First presentation from dose exploration cohorts in an expanded trial addressing urinary safety of the novel combination therapy in higher risk patients with Myelodysplastic Syndromes (MDS) Study demonstrates [...]

Novo Nordisk A/S: Share repurchase programme

26/03/2018 - 14:23

Bagsværd, Denmark, 26 March 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]

Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement With Lonza Bioscience Solutions

26/03/2018 - 14:05

SAN DIEGO, March 26, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today announced that its wholly-owned subsidiary, Samsara Sciences, Inc. (“Samsara”), a provider of highly specialized [...]

Physeon GmbH to Present at MedTech Strategist Innovation Summit - Dublin, Ireland April 17-19, 2018

26/03/2018 - 14:00

SCHAFFHAUSEN, Switzerland, March 26, 2018 (GLOBE NEWSWIRE) -- Physeon® GmbH, (“Physeon” or the “Company”), a leading developer of medical technology products for venous access, today announced that the Company will be a [...]

Drug Master File for Prostate Imaging Product Filed with the FDA

26/03/2018 - 14:00

MELBOURNE, Australia and INDIANAPOLIS, March 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix Group”, “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]

Tauriga Sciences, Inc. Elects to Change the Name of its Recently Formed Delaware Subsidiary to: Tauriga Biz Dev Corp.

26/03/2018 - 14:00

NEW YORK, NY, March 26, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]

Catalyst Biosciences Receives $1.5 Million In Two Milestone Payments for Neuronal Nicotinic Receptor (NNR) Asset

26/03/2018 - 14:00

The TC-6499 asset sale may provide up to $35.5 million in remaining development, regulatory and commercial milestone payments plus net sales royalties and sub-license fees SOUTH SAN FRANCISCO, Calif., March 26, 2018 ( [...]

Trillium Dental Announces New Brand Identity

26/03/2018 - 14:00

OTTAWA, March 26, 2018 (GLOBE NEWSWIRE) -- Trillium Dental ®, recognized as Ottawa’s largest name in dentistry, has undergone a total brand review and today launches a new brand identity. The new brand offers a richer [...]

Aeglea BioTherapeutics Appoints Dr. Ivana Magovčević-Liebisch to Board of Directors

26/03/2018 - 14:00

AUSTIN, Texas, March 26, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with [...]

AMAG Pharmaceuticals Submits a New Drug Application to the U.S. Food and Drug Administration for Bremelanotide for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women

26/03/2018 - 14:00

WALTHAM, Mass., March 26, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for [...]

Poseida to Present P-BCMA-101 Phase 1 Data at the American Association for Cancer Research (AACR) Annual Meeting 2018

26/03/2018 - 14:00

SAN DIEGO, March 26, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced that [...]